HALOZYME THERAPEUTICS (UK) Today

Equity ratings for HALOZYME THERAPEUTICS INC are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 20th of August 2020 and ending today, the 10th of August 2022. Click here to learn more.
HALOZYME THERAPEUTICS INC cannot be verified against its exchange. It appears HALOZYME THERAPEUTICS is not available for investing at the moment. Please verify the symbol is currently traded on London Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

HALOZYME THERAPEUTICS Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. HALOZYME THERAPEUTICS's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding HALOZYME THERAPEUTICS or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
HALOZYME THERAPEUTICS is not yet fully synchronised with the market data
HALOZYME THERAPEUTICS has some characteristics of a very speculative penny stock
HALOZYME THERAPEUTICS has high likelihood to experience some financial distress in the next 2 years
Over 96.0% of the company shares are owned by institutions such as pension funds
President CEO, DirectorHelen Torley
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of HALOZYME THERAPEUTICS's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Not RatedUndervalued
HALOZYME THERAPEUTICS INC (0J2O) is traded on London Stock Exchange in UK and employs 136 people. The company currently falls under 'Mid-Cap' category with current market capitalization of 2.96 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate HALOZYME THERAPEUTICS's market, we take the total number of its shares issued and multiply it by HALOZYME THERAPEUTICS's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. HALOZYME THERAPEUTICS has 143.95 M outstanding shares. HALOZYME THERAPEUTICS INC has accumulated about 764.31 M in cash with 118.59 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.37.
Check HALOZYME THERAPEUTICS Probability Of Bankruptcy

HALOZYME Stock Against Markets

Picking the right benchmark for HALOZYME THERAPEUTICS stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in HALOZYME THERAPEUTICS stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for HALOZYME THERAPEUTICS is critical whether you are bullish or bearish towards HALOZYME THERAPEUTICS INC at a given time.
HALOZYME THERAPEUTICS INC cannot be verified against its exchange. It appears HALOZYME THERAPEUTICS is not available for investing at the moment. Please verify the symbol is currently traded on London Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

Try Other Stock Suggestions

HALOZYME THERAPEUTICS Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with HALOZYME THERAPEUTICS stock to make a market-neutral strategy. Peer analysis of HALOZYME THERAPEUTICS could also be used in its relative valuation, which is a method of valuing HALOZYME THERAPEUTICS by comparing valuation metrics with similar companies.
American AirlinesAlcoa CorpApple IncBest BuyCitigroupSentinelone IncCVS CorpChevron CorpHome DepotInternational BusinessIntel CorpMetlifeATT IncTarget CorpUnited Parcel Service
 Risk & Return  Correlation

HALOZYME THERAPEUTICS Corporate Directors

HALOZYME THERAPEUTICS corporate directors refer to members of a HALOZYME THERAPEUTICS board of directors. The board of directors generally takes responsibility for the HALOZYME THERAPEUTICS's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of HALOZYME THERAPEUTICS's board members must vote for the resolution. The HALOZYME THERAPEUTICS board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Matthew Posard - Independent DirectorProfile
Bernadette Connaughton - DirectorProfile
Randal Kirk - Independent DirectorProfile
Jeffrey Henderson - Independent DirectorProfile

Invested in HALOZYME THERAPEUTICS INC?

You need to understand the risk of investing before taking a position in HALOZYME THERAPEUTICS. The danger of trading HALOZYME THERAPEUTICS INC is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of HALOZYME THERAPEUTICS is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than HALOZYME THERAPEUTICS. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile HALOZYME THERAPEUTICS is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Trending Equities. Note that the HALOZYME THERAPEUTICS information on this page should be used as a complementary analysis to other HALOZYME THERAPEUTICS's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Other Tools for HALOZYME Stock

When running HALOZYME THERAPEUTICS price analysis, check to measure HALOZYME THERAPEUTICS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HALOZYME THERAPEUTICS is operating at the current time. Most of HALOZYME THERAPEUTICS's value examination focuses on studying past and present price action to predict the probability of HALOZYME THERAPEUTICS's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move HALOZYME THERAPEUTICS's price. Additionally, you may evaluate how the addition of HALOZYME THERAPEUTICS to your portfolios can decrease your overall portfolio volatility.
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go